Gilead Sciences
GILD
#95
Rank
A$251.46 B
Marketcap
A$202.60
Share price
0.30%
Change (1 day)
15.97%
Change (1 year)

Gilead Sciences (GILD) - Total assets

Total assets on the balance sheet as of December 2025 : A$85.33 Billion

According to Gilead Sciences's latest financial reports the company's total assets are A$85.33 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Gilead Sciences - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2025-12-31A$88.12 B-7.09%
2024-12-31A$94.84 B4.02%
2023-12-31A$91.18 B-1.77%
2022-12-31A$92.82 B-0.96%
2021-12-31A$93.72 B5.36%
2020-12-31A$88.96 B1.07%
2019-12-31A$88.02 B-2.62%
2018-12-31A$90.38 B0.4%
2017-12-31A$90.02 B13.89%
2016-12-31A$79.04 B11.34%
2015-12-31A$70.99 B67.6%
2014-12-31A$42.35 B67.33%
2013-12-31A$25.31 B23.85%
2012-12-31A$20.43 B21.12%
2011-12-31A$16.87 B47.87%
2010-12-31A$11.41 B5.71%
2009-12-31A$10.79 B9.81%
2008-12-31A$9.83 B47.33%
2007-12-31A$6.67 B28.76%
2006-12-31A$5.18 B0.7%
2005-12-31A$5.14 B84.76%
2004-12-31A$2.78 B33.2%
2003-12-31A$2.09 B-8.52%
2002-12-31A$2.28 B46.82%
2001-12-31A$1.55 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
A$288.01 B 237.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$300.95 B 252.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$193.67 B 126.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$162.61 B 90.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$130.96 B 53.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$42.56 B-50.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$9.60 B-88.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$37.07 B-56.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$197.87 B 131.89%๐Ÿ‡บ๐Ÿ‡ธ USA